Amanda E Garza (@amandaegarza10) 's Twitter Profile
Amanda E Garza

@amandaegarza10

Scientist, Proud Texan living the dream in Boston!

ID: 1383212077

calendar_today27-04-2013 00:43:31

1,1K Tweet

315 Takipçi

890 Takip Edilen

The Scientist (@thescientistllc) 's Twitter Profile Photo

scRNA-seq allows scientists to study biological pathways at unprecedented resolution. Arpita Kulkarni from @HarvardMed’s Single Cell Core will share how to design a successful scRNA-seq experiment from the wet lab perspective. Register now: bit.ly/3zCvnew

scRNA-seq allows scientists to study biological pathways at unprecedented resolution.

Arpita Kulkarni from @HarvardMed’s Single Cell Core will share how to design a successful scRNA-seq experiment from the wet lab perspective.

Register now: bit.ly/3zCvnew
Amanda E Garza (@amandaegarza10) 's Twitter Profile Photo

Women in STEM becoming independent: Embrace failures as part of the journey to success | Journal of Experimental Medicine | Rockefeller University Press. Great read & thanks ⁦Fern Koay 郭⁩ & others for sharing your experiences & advice. rupress.org/jem/article/22…

Eddy Saad (@eddy_saad) 's Twitter Profile Photo

Hello #MedTwitter! I’m Eddy Saad, a USJ graduate 🇱🇧 and currently a postdoc fellow studying kidney cancer and immunotherapy 🤓 Dana-Farber Harvard Medical School Incredibly grateful for the opportunity to be applying for the #InternalMedicine #Match2025 ! AAMC ID: 16349429 #IMG

Hello #MedTwitter!

I’m Eddy Saad, a <a href="/USJLiban/">USJ</a> graduate 🇱🇧 and currently a postdoc fellow studying kidney cancer and immunotherapy 🤓 <a href="/DanaFarber/">Dana-Farber</a> <a href="/harvardmed/">Harvard Medical School</a> 

Incredibly grateful for the opportunity to be applying for the #InternalMedicine #Match2025 !

AAMC ID: 16349429 #IMG
Eli Van Allen (@vanallenlab) 's Twitter Profile Photo

Hi folks, we have new faculty open search in Dana-Farber Division of Population Sciences Dana-Farber Harvard Medical School, seeking folks interested in launching an independent research program across our very diverse and interdisciplinary set interests! See link for more info: careercenter.asco.org/job/7622758/as…

Amanda E Garza (@amandaegarza10) 's Twitter Profile Photo

Congratulations John Paul 🎉🎥 on all your hardwork. You’ve earned this win and I am so proud. Keep shining & chasing your dreams! #welldeserved

Fern Koay 郭 (@_fernace) 's Twitter Profile Photo

Sharing our latest work Journal of Experimental Medicine! We've uncovered that P2RX7 regulates unconventional T cells selectively, particularly subsets that co-produce IFN-γ & IL-4. Hoping this helps more discoveries in the role of these innate-like cells, using inhibitors from the P2RX7/ARTC2 field!

Rajae Talbi (@talbirajae) 's Twitter Profile Photo

If you are in the Boston area and interested in neuroendocrinology research then this is for you :) Come join us next Monday for the Neuroendocrine Dialogs with two talks from @NatMachado_PhD lab about the brain circuits regulating thermoregulation HarvardBrainScience

If you are in the Boston area and interested in neuroendocrinology research then this is for you :)
Come join us next Monday for the Neuroendocrine Dialogs with two talks from @NatMachado_PhD lab about the brain circuits regulating thermoregulation 
<a href="/harvardbrainsci/">HarvardBrainScience</a>
SJ (@sjohri20) 's Twitter Profile Photo

1/ 🚀 Excited to kick off the new year with our latest study, now published in Nature Medicine! 🌟Presenting CRAFT-MD, a novel framework to rigorously evaluate LLMs for clinical conversational reasoning! Let's dive in! 🧵 #HNY2025

Dana-Farber News (@danafarbernews) 's Twitter Profile Photo

Riaz Gillani, MD, and Ryan Collins in Eli Van Allen Dana-Farber report in Science Magazine that rare germline genetic abnormalities increase the risk of pediatric solid cancers, findings that could help improve treatments and screening. ➡️ bit.ly/3BQ04hK

Riaz Gillani, MD, and <a href="/RyanLCollins13/">Ryan Collins</a> in <a href="/VanAllenLab/">Eli Van Allen</a> <a href="/DanaFarber/">Dana-Farber</a> report in <a href="/ScienceMagazine/">Science Magazine</a> that rare germline genetic abnormalities increase the risk of pediatric solid cancers, findings that could help improve treatments and screening.

➡️ bit.ly/3BQ04hK
SJ (@sjohri20) 's Twitter Profile Photo

🚀Excited to share our new paper, now published in Nature Communications! ✨ We present BEANIE, a nonparametric method that reduces false positives when analyzing differential gene signature expression in multi-patient clinical scRNA-seq cohorts Eli Van Allen 🧪🧵nature.com/articles/s4146…

Josephine Yates (@joyatesresearch) 's Twitter Profile Photo

Excited to share our new paper, "New horizons at the interface of artificial intelligence and translational cancer research", out now in Cancer Cell ! With Eli Van Allen, we explore how AI is reshaping oncology—from discovery to the clinic. 🔗 sciencedirect.com/science/articl…

Excited to share our new paper, "New horizons at the interface of artificial intelligence and translational cancer research", out now in <a href="/Cancer_Cell/">Cancer Cell</a> !
With <a href="/VanAllenLab/">Eli Van Allen</a>, we explore how AI is reshaping oncology—from discovery to the clinic.
🔗 sciencedirect.com/science/articl…
Iñigo Landa (@inigo_landa) 's Twitter Profile Photo

We are looking for a candidate to apply for the FRM postdoctoral fellowship in late May. Join the thyroid cancer genetics and biology group at Gustave Roussy Research 🔬 ! If interested, check attachment and email me at [email protected] drive.google.com/file/d/1qY1rtI…

Rajae Talbi (@talbirajae) 's Twitter Profile Photo

So proud of Safa Bouabid!! Happy to see this beautiful piece of work finally out and even more excited for what’s next! She is on the job market and brings creativity, rigor and kindness to everything she does, and she’s a fantastic mentor. Reach out to her if you’re hiring!! :)

Tess O'Meara, MD, MHS (@tess_omeara) 's Twitter Profile Photo

T-DXd may be a new 1L option for HER2+ metastatic #breastcancer, but which other pts could benefit? Ongoing trials are studying T-DXd in combo with endocrine and targeted therapies as well as in HER2 null disease and early-stage/residual disease. Thanks OncLive.com for hosting!

Amanda E Garza (@amandaegarza10) 's Twitter Profile Photo

A bite-size 20-min listen filled with exciting possibilities for the future of patient care & research. Excited to see where AI takes us newsweek.com/nw-ai/re-human…